Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer	Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm	Active, not recruiting	Not applicable	2026-04-29		NCT03862911

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Aberdeen Royal Infirmary	2
Beacon Hospital, Ireland	2
Beatson West of Scotland Cancer Centre	4
Bon Secours Cork Cancer Centre	2
British Columbia Cancer Agency	58
Cancer Research UK Edinburgh Centre	1
Cancer Trials Ireland	26
London Regional Cancer Program, Canada	1
Riverina Cancer Care Centre	1
The Alfred	22
Tom Baker Cancer Centre	7
UPMC Hillman Cancer Centre	1
Walker Family Cancer Centre	1

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aberdeen Royal Infirmary	Aberdeen	United Kingdom	1
Alfred Hospital	Melbourne	Australia	30
BC Cancer	Victoria	Canada	1
BC Cancer	Kelowna	Canada	2
BC Cancer	Vancouver	Canada	3
BC Cancer	Surrey	Canada	2
BC Cancer - Prince George	Prince George	Canada	3
Beacon Hospital	Dublin	Ireland	1
Beatson West of Scotland Cancer Centre	Glasgow	United Kingdom	18
Bon Secours Radiotherapy Cork in partnership with UPMC Hillman Cancer Centre	Cork	Ireland	2
Cancer Care Griffith	Griffith	Australia	1
Edinburgh Cancer Centre	Edinburgh	United Kingdom	1
London Health Sciences Centre	London	Canada	39
Riverina Cancer Care Centre	Wagga Wagga	Australia	3
St. Luke's Radiation Oncology Network	Rathgar	Ireland	1
Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre	Calgary	Canada	1
Walker Family Cancer Centre	Saint Catharines	Canada	1